1. Home
  2. HOWL vs STBX Comparison

HOWL vs STBX Comparison

Compare HOWL & STBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • STBX
  • Stock Information
  • Founded
  • HOWL 2017
  • STBX 2019
  • Country
  • HOWL United States
  • STBX Malaysia
  • Employees
  • HOWL N/A
  • STBX N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • STBX Advertising
  • Sector
  • HOWL Health Care
  • STBX Consumer Discretionary
  • Exchange
  • HOWL Nasdaq
  • STBX Nasdaq
  • Market Cap
  • HOWL 62.4M
  • STBX 59.7M
  • IPO Year
  • HOWL 2021
  • STBX 2022
  • Fundamental
  • Price
  • HOWL $1.23
  • STBX $0.31
  • Analyst Decision
  • HOWL Strong Buy
  • STBX
  • Analyst Count
  • HOWL 3
  • STBX 0
  • Target Price
  • HOWL $9.00
  • STBX N/A
  • AVG Volume (30 Days)
  • HOWL 241.7K
  • STBX 1.1M
  • Earning Date
  • HOWL 03-11-2025
  • STBX 03-25-2025
  • Dividend Yield
  • HOWL N/A
  • STBX N/A
  • EPS Growth
  • HOWL N/A
  • STBX N/A
  • EPS
  • HOWL N/A
  • STBX N/A
  • Revenue
  • HOWL $1,885,000.00
  • STBX $6,174,236.00
  • Revenue This Year
  • HOWL $36.45
  • STBX N/A
  • Revenue Next Year
  • HOWL $296.58
  • STBX N/A
  • P/E Ratio
  • HOWL N/A
  • STBX N/A
  • Revenue Growth
  • HOWL N/A
  • STBX N/A
  • 52 Week Low
  • HOWL $1.03
  • STBX $0.14
  • 52 Week High
  • HOWL $6.89
  • STBX $5.28
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 44.53
  • STBX 46.22
  • Support Level
  • HOWL $1.18
  • STBX $0.26
  • Resistance Level
  • HOWL $1.29
  • STBX $0.42
  • Average True Range (ATR)
  • HOWL 0.10
  • STBX 0.11
  • MACD
  • HOWL 0.00
  • STBX 0.04
  • Stochastic Oscillator
  • HOWL 56.10
  • STBX 15.66

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About STBX Starbox Group Holdings Ltd.

Starbox Group Holdings Ltd engages in developing cash rebate, digital advertising, and payment solution business ecosystem targeting micro, small, and medium enterprises. Through the firm's subsidiaries in Malaysia, it connects retail merchants with retail shoppers to facilitate transactions through cash rebates offered by retail merchants, provide digital advertising services to advertisers, and provide payment solution services to merchants. Substantially all of its current operations are located in Malaysia. It operates in five segments include Cash rebate, payment solution, and media booking, Advertising services, Software licensing and Production services, Marketing and Promotional campaign services segment.

Share on Social Networks: